Literature DB >> 25801170

Activation of a primed RING E3-E2-ubiquitin complex by non-covalent ubiquitin.

Lori Buetow1, Mads Gabrielsen1, Nahoum G Anthony2, Hao Dou1, Amrita Patel1, Hazel Aitkenhead1, Gary J Sibbet1, Brian O Smith3, Danny T Huang4.   

Abstract

RING ubiquitin ligases (E3) recruit ubiquitin-conjugate enzymes (E2) charged with ubiquitin (Ub) to catalyze ubiquitination. Non-covalent Ub binding to the backside of certain E2s promotes processive polyUb formation, but the mechanism remains elusive. Here, we show that backside bound Ub (Ub(B)) enhances both RING-independent and RING-dependent UbcH5B-catalyzed donor Ub (Ub(D)) transfer, but with a more prominent effect in RING-dependent transfer. Ub(B) enhances RING E3s' affinities for UbcH5B-Ub, and RING E3-UbcH5B-Ub complex improves Ub(B)'s affinity for UbcH5B. A comparison of the crystal structures of a RING E3, RNF38, bound to UbcH5B-Ub in the absence and presence of Ub(B), together with molecular dynamics simulation and biochemical analyses, suggests Ub(B) restricts the flexibility of UbcH5B's α1 and α1β1 loop. Ub(B) supports E3 function by stabilizing the RING E3-UbcH5B-Ub complex, thereby improving the catalytic efficiency of Ub transfer. Thus, Ub(B) serves as an allosteric activator of RING E3-mediated Ub transfer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801170     DOI: 10.1016/j.molcel.2015.02.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  58 in total

1.  A Bifunctional Role for the UHRF1 UBL Domain in the Control of Hemi-methylated DNA-Dependent Histone Ubiquitylation.

Authors:  Paul A DaRosa; Joseph S Harrison; Alex Zelter; Trisha N Davis; Peter Brzovic; Brian Kuhlman; Rachel E Klevit
Journal:  Mol Cell       Date:  2018-11-01       Impact factor: 17.970

2.  A conformational switch regulates the ubiquitin ligase HUWE1.

Authors:  Bodo Sander; Wenshan Xu; Martin Eilers; Nikita Popov; Sonja Lorenz
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

3.  BMI1-RING1B is an autoinhibited RING E3 ubiquitin ligase.

Authors:  Asad M Taherbhoy; Oscar W Huang; Andrea G Cochran
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

4.  Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase activity.

Authors:  Joshua D Wright; Peter D Mace; Catherine L Day
Journal:  Nat Struct Mol Biol       Date:  2015-12-14       Impact factor: 15.369

Review 5.  Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.

Authors:  Mehmet Gundogdu; Helen Walden
Journal:  Protein Sci       Date:  2019-08-23       Impact factor: 6.725

6.  Mechanism of catalysis, E2 recognition, and autoinhibition for the IpaH family of bacterial E3 ubiquitin ligases.

Authors:  Alexander F A Keszei; Frank Sicheri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

7.  A novel MKRN3 nonsense mutation causing familial central precocious puberty.

Authors:  Athanasios Christoforidis; Nicos Skordis; Pavlos Fanis; Meropi Dimitriadou; Maria Sevastidou; Marie M Phelan; Vassos Neocleous; Leonidas A Phylactou
Journal:  Endocrine       Date:  2017-01-28       Impact factor: 3.633

8.  Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B.

Authors:  Shengjian Li; Yu-He Liang; Jennifer Mariano; Meredith B Metzger; Daniel K Stringer; Ventzislava A Hristova; Jess Li; Paul A Randazzo; Yien Che Tsai; Xinhua Ji; Allan M Weissman
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

Review 9.  Structural insights into the catalysis and regulation of E3 ubiquitin ligases.

Authors:  Lori Buetow; Danny T Huang
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-03       Impact factor: 94.444

10.  Conformational Dynamics and Allostery in E2:E3 Interactions Drive Ubiquitination: gp78 and Ube2g2.

Authors:  Kalyan S Chakrabarti; Jess Li; Ranabir Das; R Andrew Byrd
Journal:  Structure       Date:  2017-04-20       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.